Key result
XGBoost with HDL-related inflammatory ratios classifies prevalent CHD with ~0.89 AUROC.
Why the study?
The utility of HDL-related inflammatory ratios integrating lipid metabolism and inflammatory pathways for coronary heart disease classification in a large population-based dataset needed evaluation.
Do machine learning models incorporating HDL-related inflammatory ratios accurately classify prevalent coronary heart disease in US adults aged >=20 years?
Cross-Sectional (n=14,745)
Yes
Do machine learning models incorporating HDL-related inflammatory ratios accurately classify prevalent coronary heart disease in US adults aged >=20 years?
Machine learning models, particularly XGBoost, incorporating routine blood test-derived HDL-related inflammatory ratios (such as MHR and NHR) demonstrate high discrimination and specificity for classifying prevalent coronary heart disease in US adults.
XGBoost models with HDL ratios show high accuracy for prevalent CHD classification; hypothesis-generating and requires prospective validation before clinical use.
High-density lipoprotein (HDL)-related inflammatory ratios (monocyte-to-HDL cholesterol ratio [MHR], lymphocyte-to-HDL cholesterol ratio, neutrophil-to-HDL cholesterol ratio [NHR], platelet-to-HDL cholesterol ratio) represent composite biomarkers integrating lipid metabolism and inflammatory pathways. We developed machine learning models to evaluate their utility in coronary heart disease (CHD) classification using a large population-based dataset. We analyzed data from the National Health and Nutrition Examination Survey 2009 to 2020, including 14,745 US adults aged ≥20 years (mean age 51.8 ± 17.6 years). Self-reported CHD diagnosis was the outcome variable. Machine learning models (eXtreme gradient boosting, random forest, logistic regression) were developed to evaluate cross-sectional associations between HDL-related inflammatory ratios and CHD prevalence. Self-reported CHD prevalence was 5.7% (n = 840). All HDL-related inflammatory ratios were significantly elevated in CHD patients: MHR (0.54 ± 0.35 vs 0.42 ± 0.23, P < .001), lymphocyte-to-HDL cholesterol ratio (2.05 ± 3.12 vs 1.55 ± 1.02, P < .001), and NHR (4.06 ± 2.89 vs 3.11 ± 1.77, P < .001). eXtreme gradient boosting demonstrated optimal performance with an area under the receiver operating characteristic curve of 0.8892, accuracy of 96.55%, and precision of 86.00%. SHapley Additive exPlanations analysis identified age as the most important predictor, with MHR and NHR ranking among the top 5 features. Machine learning models incorporating HDL-related inflammatory biomarkers achieved high discrimination (area under the receiver operating characteristic curve = 0.8892) for identifying cross-sectional associations with CHD prevalence. These findings reveal significant cross-sectional associations between HDL-related inflammatory ratios and CHD prevalence, rather than predictive relationships for incident events. These readily available biomarkers from routine blood tests provide substantial value for cardiovascular risk stratification. Prospective validation is warranted to establish their utility for predicting incident CHD events.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) conducted a cross-sectional in Coronary heart disease (CHD) (n=14,745). High-density lipoprotein-related inflammatory ratios (MHR, LHR, NHR, PHR) in machine learning models vs. Participants without self-reported CHD / alternative machine learning algorithms was evaluated on Self-reported coronary heart disease (CHD) prevalence classification (AUROC 0.8892, 95% CI 0.863–0.916, p=<0.001). XGBoost models incorporating HDL-related inflammatory ratios achieved an AUROC of 0.8892 (95% CI 0.863-0.916) and 96.55% accuracy for classifying prevalent coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: